Helius Medical Technologies Inc. (HSDT) |
|
0.4176 -0.004 (-0.88%)
|
09-20 19:50 |
|
Open: |
0.42 |
Pre. Close: |
0.4213 |
|
High:
|
0.4348 |
Low:
|
0.41 |
|
Volume:
|
231,128 |
Market Cap:
|
19M |
|
|
|
|
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 25 full-time employees. The firm focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. The firm is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device. The device, when used in combination with physiotherapy, is designed to enhance the brain's ability to compensate for damage due to trauma or disease. The firm's PoNS device is designed to induce cranial nerve non-invasive neuromodulation through an increase in stimulation of the facial and trigeminal nerves, which innervate the tongue. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation. The PoNS device is an electrical pulse generator that delivers controlled electrical stimulation to the tongue. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.43 - 0.433 |
0.433 - 0.435 |
|
Low:
|
0.404 - 0.407 |
0.407 - 0.41 |
|
Close:
|
0.416 - 0.42 |
0.42 - 0.424 |
|
Technical analysis |
as of: 2020-09-18 4:31:54 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 0.56 One year: 0.62 |
| Support: |
Support1: 0.38 Support2: 0.32 |
| Resistance: |
Resistance1: 0.48 Resistance2: 0.54 |
| Pivot: |
0.44 |
| Moving Average: |
MA(5): 0.43 MA(20): 0.44
MA(100): 0.49 MA(250): 0.72 |
| MACD: |
MACD(12,26): -0.02  Signal(9): -0.02 |
| Stochastic oscillator: |
%K(14,3): 28.09 %D(3): 30.44 |
| RSI: |
RSI(14): 41.29 |
| 52-week: |
High: 1.84 Low: 0.25 Change(%): -75.9 |
| Average Vol(K): |
3-Month: 48618 10-Days: 20422 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.HSDT has closed above bottom band by 31.9%. Bollinger Bands are 36.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 08 Sep 2020
Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS™) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury - GlobeNewswire
Mon, 31 Aug 2020
Helius Medical Technologies, Inc. to Present at Three Upcoming Investor Conferences in September - Yahoo Finance
Tue, 25 Aug 2020
Chairman and CEO of Bucks County medical device company resigns - Philadelphia Business Journal
Tue, 25 Aug 2020
Helius Medical Technologies CEO resigns - Seeking Alpha
Wed, 12 Aug 2020
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Wed, 12 Aug 2020
Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results - GlobeNewswire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
45 |
| Shares Float (M) |
37 |
|
% Held by Insiders
|
20.02 |
|
% Held by Institutions
|
26.57 |
|
Shares Short (K)
|
980 |
|
Shares Short P. Month (K)
|
1,170 |
Stock Financials |
|
EPS
|
-0.604 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.140 |
|
Profit Margin
|
|
|
Operating Margin
|
-2938.13 |
|
Return on Assets (ttm)
|
-87.4 |
|
Return on Equity (ttm)
|
-198.5 |
|
Qtrly Rev. Growth
|
-74.3 |
|
Gross Profit (p.s.)
|
0.014 |
|
Sales Per Share
|
0.014 |
|
EBITDA (p.s.)
|
-0.408 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-17 |
|
Levered Free Cash Flow (M)
|
-9 |
Stock Valuations |
|
PE Ratio
|
-0.69 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.98 |
|
Price to Sales
|
29.43 |
|
Price to Cash Flow
|
-1.12 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
